Showing results (131-140 of 4,635) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|August 19, 2006
Celecoxib can induce cell death independently of cyclooxygenase-2, p53, Mdm2, c-Abl and reactive oxygen speciesSue Haupt, Jackie Kleinstern, Ygal Haupt, et al.
Anti-Cancer Drugs|August 19, 2006
Antileukemia activity of MSFTZ-a novel flavanone analogQiaojun He, Runping Li, Liang Fang, et al.
Anti-Cancer Drugs|August 19, 2006
Gemcitabine and cisplatin after radical cystectomy for bladder cancer in an adjuvant setting: feasibility study from the Genito-Urinary Group of the French Federation of Cancer CentersAude Fléchon, Karim Fizazi, Sophie Gourgou-Bourgade, et al.
Anti-Cancer Drugs|August 19, 2006
A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatinMunetaka Takekuma, Yasuyuki Hirashima, Nobutaka Takahashi, et al.
Anti-Cancer Drugs|August 19, 2006
Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: a Slovenian perspectivePeter Piskur, Monika Sonc, Tanja Cufer, et al.
Anti-Cancer Drugs|June 10, 2020
Predictors of resistance to abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer in post-docetaxel setting: a single-center cohort studyTomislav Omrčen, Davor Eterović, Eduard Vrdoljak
Anti-Cancer Drugs|May 21, 2021
Aurora kinase inhibitor VX-680 enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapyJunting Kou, Xuewei Wang, Yuan Wei, et al.
Anti-Cancer Drugs|May 21, 2021
Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axisYongjun Sun, Jie Ma, Junkai Lin, et al.
Anti-Cancer Drugs|April 30, 2021
Hsa_circ_0069094 knockdown inhibits cell proliferation, migration, invasion and glycolysis, while induces cell apoptosis by miR-661/HMGA1 axis in breast cancerChao Sui, Wei Qu, Yanfen Lian, et al.
Anti-Cancer Drugs|April 30, 2021
Actein antagonizes colorectal cancer through blocking PI3K/Akt pathways by downregulating IMPDH2Liwei Yan, Dandan Wang, Xiaoming Liu, et al.
Pageof 464